Literature DB >> 23041604

Double umbilical cord blood transplantation: a study of early engraftment kinetics in leukocyte subsets using HLA-specific monoclonal antibodies.

Judith A E Somers1, Anneke Brand, Yvette van Hensbergen, Arend Mulder, Machteld Oudshoorn, Kees Sintnicolaas, Jan-Willem Gratama, J H Frederik Falkenburg, Eric Braakman, Jan J Cornelissen.   

Abstract

Single cord blood unit (CBU) predominance is usually established within the first month after double umbilical cord blood transplantation (UCBT). However, the kinetics of engraftment of the different leukocyte subsets and the mechanism of graft predominance is largely unknown. To investigate whether a differential engraftment might reveal a specific subset that could play a key role in the mechanism of graft predominance, we studied early engraftment kinetics of different leukocyte subpopulations by flow cytometry using human monoclonal antigen-specific human leukocyte antigen antibodies, directed against mismatched human leukocyte antigen-A or -B antigens between recipient and CBUs. Twenty-two patients, who had received a double UCBT preceded by a reduced-intensity conditioning regimen, were evaluated at days +11, +18, +25, and +32 posttransplantation. Single CBU predominance in the various leukocyte subsets was established within 18 days posttransplantation. CD4+ T cells of the dominant CBU showed early peripheral blood expansion. Moreover, chimerism in CD4+ and CD8+ T cell and natural killer cell subsets at day +11 was predictive of ultimate graft predominance. These findings show that engraftment kinetics of the various leukocyte subsets vary considerably after double UCBT and may suggest an important role for CD4+ T cells in a presumed alloreactive graft-versus-graft rejection.
Copyright © 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23041604     DOI: 10.1016/j.bbmt.2012.09.022

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  16 in total

1.  Natural killer cell licensing after double cord blood transplantation is driven by the self-HLA class I molecules from the dominant cord blood.

Authors:  Nicolas Guillaume; Pascale Loiseau; Katia Gagne; Hélène Moins Teissserenc; Jean-Michel Cayuela; Guylaine Henry; Marie Robin; Régis Peffault de Latour; Eliane Gluckman; Gérard Socié; Christelle Retiere; Nicolas Dulphy; Antoine Toubert
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

2.  Circulating endothelial cell enumeration demonstrates prolonged endothelial damage in recipients of myeloablative allogeneic stem cell transplantation.

Authors:  Nick Beije; Jurjen Versluis; Jaco Kraan; Jan W Gratama; Stefan Sleijfer; Jan J Cornelissen
Journal:  Haematologica       Date:  2015-02-20       Impact factor: 9.941

Review 3.  Can we make a better match or mismatch with KIR genotyping?

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

4.  Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.

Authors:  Nelli Bejanyan; Claudio G Brunstein; Qing Cao; Aleksandr Lazaryan; Xianghua Luo; Julie Curtsinger; Rohtesh S Mehta; Erica Warlick; Sarah A Cooley; Bruce R Blazar; Jeffrey S Miller; Daniel Weisdorf; John E Wagner; Michael R Verneris
Journal:  Blood Adv       Date:  2018-04-24

5.  General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation.

Authors:  Rima M Saliba; Katayoun Rezvani; Ann Leen; Jeffrey Jorgensen; Nina Shah; Chitra Hosing; Simrit Parmar; Betul Oran; Amanda Olson; Gabriela Rondon; Julianne Chen; Charles Martinez; Amir Hamdi; Rohtesh S Mehta; Roy F Chemaly; Ila M Saunders; Catherine M Bollard; Elizabeth J Shpall
Journal:  Biol Blood Marrow Transplant       Date:  2015-02-20       Impact factor: 5.742

Review 6.  Graft predominance after double umbilical cord blood transplantation: a review.

Authors:  Jan J Cornelissen; Burak Kalin; Cor H J Lamers
Journal:  Stem Cell Investig       Date:  2017-05-26

Review 7.  Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Virulence       Date:  2016-07-06       Impact factor: 5.882

Review 8.  Advances in umbilical cord blood manipulation-from niche to bedside.

Authors:  Troy C Lund; Anthony E Boitano; Colleen S Delaney; Elizabeth J Shpall; John E Wagner
Journal:  Nat Rev Clin Oncol       Date:  2014-12-16       Impact factor: 66.675

9.  The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

Authors:  Suzanna M van Walraven; Anneke Brand; Jack N A Bakker; Martin B A Heemskerk; Suzan Nillesen; Marc B Bierings; Laura B Bungener; Bouke G Hepkema; Arjan Lankester; Arnold van der Meer; Kees Sintnicolaas; Judith A E Somers; Eric Spierings; Marcel G J Tilanus; Christien E M Voorter; Jan J Cornelissen; Machteld Oudshoorn
Journal:  Haematologica       Date:  2016-08-25       Impact factor: 9.941

10.  Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.

Authors:  Judith A E Somers; Eric Braakman; Bronno van der Holt; Eefke J Petersen; Erik W A Marijt; Cynthia Huisman; Kees Sintnicolaas; Machteld Oudshoorn; Marlies E Groenendijk-Sijnke; Anneke Brand; Jan J Cornelissen
Journal:  Haematologica       Date:  2014-08-08       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.